South San Francisco, CA, United States of America

Martin Holan

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tenaya Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martin Holan. Retrieved from https://idiyas.com/inventor/martin-holan-22num0wi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Martin Holan: Innovator in Therapeutic Compounds

Introduction

Martin Holan is a distinguished inventor based in South San Francisco, CA. He has made significant contributions to the field of therapeutic compounds, particularly in the development of inhibitors for various diseases and disorders.

Latest Patents

Holan holds a patent for "Fluoroalkyl-oxadiazoles and uses thereof." This patent describes compounds identified as inhibitors of HDAC6 activity, which can be utilized in treating a range of medical conditions. His innovative work in this area has the potential to impact the treatment landscape significantly.

Career Highlights

Currently, Martin Holan is associated with Tenaya Therapeutics, Inc., where he continues to advance his research and development efforts. His expertise in medicinal chemistry and compound development has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Holan collaborates with talented professionals in his field, including Snahel Patel and Mohammad A Mandegar. These partnerships enhance the research and development process, fostering innovation and progress in therapeutic solutions.

Conclusion

Martin Holan's contributions to the field of therapeutic compounds exemplify the impact of innovative thinking in medicine. His work continues to pave the way for advancements in treatment options for various diseases and disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…